Dehace Retard

Dehace Retard contains Dihydrocodeine Tartrate, an opioid analgesic used for moderate to severe pain relief. This extended-release formulation is designed for oral use and is manufactured by G.L. Pharma GmbH.

Dehace Retard is primarily used for the management of moderate to severe pain that requires around-the-clock opioid treatment. The extended-release formulation is intended to provide long-lasting pain relief. Dihydrocodeine Tartrate, the active ingredient, is often prescribed for conditions where continuous pain management is necessary.

Common effects of Dehace Retard may include drowsiness, dizziness, and constipation. Some users may experience nausea or vomiting. These effects can vary from person to person and may diminish with regular use as the body adjusts to the medication.

Dehace Retard should be handled with care and stored out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid activities that require alertness, such as driving or operating machinery, until you know how this medication affects you.

Dehace Retard may interact with other medications, including alcohol, sedatives, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.